APA (7th ed.) Citation

D, M., F, C., A, T., S, P., A, A., L, S., . . . A, C. (2026). PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes. Cancer treatment reviews, 147, 103159. https://doi.org/10.1016/j.ctrv.2026.103159

Chicago Style (17th ed.) Citation

D, Marinelli, et al. "PD-(L)1 Containing Rechallenge Strategies in Patients with Advanced NSCLC Previously Treated with Immunotherapy: A Systematic Review and Meta-analysis Across Resistance Phenotypes." Cancer Treatment Reviews 147 (2026): 103159. https://doi.org/10.1016/j.ctrv.2026.103159.

MLA (9th ed.) Citation

D, Marinelli, et al. "PD-(L)1 Containing Rechallenge Strategies in Patients with Advanced NSCLC Previously Treated with Immunotherapy: A Systematic Review and Meta-analysis Across Resistance Phenotypes." Cancer Treatment Reviews, vol. 147, 2026, p. 103159, https://doi.org/10.1016/j.ctrv.2026.103159.